These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15869867)

  • 21. The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy.
    Wellmer J; Wellmer S; Bauer J
    Acta Neurol Scand; 2009 Apr; 119(4):233-8. PubMed ID: 19053955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential efficacy of zonisamide in refractory juvenile myoclonic epilepsy: retrospective evidence from an Irish compassionate-use case series.
    O'Rourke D; Flynn C; White M; Doherty C; Delanty N
    Ir Med J; 2007 Apr; 100(4):431-3. PubMed ID: 17566478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying the response to antiepileptic drugs: effect of past treatment history.
    Schiller Y; Najjar Y
    Neurology; 2008 Jan; 70(1):54-65. PubMed ID: 18166707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of zonisamide in childhood epilepsy after long-term treatment: a postmarketing, multi-institutional survey.
    Iinuma K; Haginoya K
    Seizure; 2004 Dec; 13 Suppl 1():S34-9; discussion S40. PubMed ID: 15511687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and tolerability of zonisamide in children with epilepsy: a retrospective review.
    Tan HJ; Martland TR; Appleton RE; Kneen R
    Seizure; 2010 Jan; 19(1):31-5. PubMed ID: 19942456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of zonisamide monotherapy in children with epilepsy.
    Seki T; Kumagai N; Maezawa M
    Seizure; 2004 Dec; 13 Suppl 1():S26-32; discussion S33. PubMed ID: 15511685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction to zonisamide.
    Baulac M
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S3-9. PubMed ID: 16413170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zonisamide: newer antiepileptic agent with multiple mechanisms of action.
    Biton V
    Expert Rev Neurother; 2004 Nov; 4(6):935-43. PubMed ID: 15853520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of zonisamide: our experience.
    Yamauchi T; Aikawa H
    Seizure; 2004 Dec; 13 Suppl 1():S41-8; discussion S49. PubMed ID: 15511689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective audit of adjunctive zonisamide in an everyday clinical setting.
    Stephen LJ; Kelly K; Wilson EA; Parker P; Brodie MJ
    Epilepsy Behav; 2010 Apr; 17(4):455-60. PubMed ID: 20207201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of zonisamide therapy: prospective follow-up survey.
    Ohtahara S; Yamatogi Y
    Seizure; 2004 Dec; 13 Suppl 1():S50-5; discussion S56. PubMed ID: 15511692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
    Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
    Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.
    Kothare SV; Kaleyias J; Mostofi N; Valencia I; Melvin JJ; Hobdell E; Khurana DS; Legido A
    Pediatr Neurol; 2006 May; 34(5):351-4. PubMed ID: 16647993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How reliable is early treatment response in predicting long-term seizure outcome?
    Schmidt D
    Epilepsy Behav; 2007 Jun; 10(4):588-94. PubMed ID: 17418644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in seizure-free patients with epilepsy on monotherapy.
    Auriel E; Landov H; Blatt I; Theitler J; Gandelman-Marton R; Chistik V; Margolin N; Gross B; Parmet Y; Andelman F; Neufeld MY
    Epilepsy Behav; 2009 Jan; 14(1):130-3. PubMed ID: 18926930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of zonisamide on serum immunoglobulins.
    Fujimoto Y; Ikoma R; Shimizu T; Shimizu A
    Arzneimittelforschung; 1990 Aug; 40(8):855-8. PubMed ID: 2242076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience.
    You SJ; Kang HC; Kim HD; Lee HS; Ko TS
    Brain Dev; 2008 Apr; 30(4):287-90. PubMed ID: 17959327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low serum leptin level is associated with zonisamide-induced weight loss in overweight female epilepsy patients.
    Kim DW; Yoo MW; Park KS
    Epilepsy Behav; 2012 Apr; 23(4):497-9. PubMed ID: 22440324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zonisamide monotherapy in a multi-group clinic.
    Newmark ME; Dubinsky S
    Seizure; 2004 Jun; 13(4):223-5. PubMed ID: 15121129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit.
    Boggs JG; Preis K
    Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.